EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
   1.14.19.64 | -999 |
- |
0.43 pmol/min/pmol P450 for the CYP719A2 variant, (R,S)-scoulerine as substrate |
673579 |
| 1.14.19.64 | -999 |
- |
CYP719A2 variant uses only (R,S)-cheilanthifoline as substrate to produce stylopine when incubating with a mixture of 0.4 microM (R,S)-cheilanthifoline and 0.4 microM S-scoulerine as substrates |
673579 |
| 1.14.19.64 | -999 |
- |
CYP719A3 and CYP719A2 do not react with columbamine, (R,S)-reticuline, (R,S)-norreticuline, (S)-N-methylcoclaurine, (S)-coclaurine, (R,S)-6-O-methylnorlaudanosoline and magnoflorine to make corresponding products with a methylenedioxy bridge |
673579 |
| 1.14.19.64 | -999 |
- |
CYP719A3 but not CYP719A2 variant converts (S)-tetrahydrocolumbamine to (S)-tetrahydroberberine |
673579 |
| 1.14.19.64 | -999 |
- |
CYP719A3 converts a mixture of 0.4 microM (R,S)-cheilanthifoline and 0.4 microM S-scoulerine as substrates to stylopine and nandinine |
673579 |
| 1.14.19.64 | 0.0000045 |
- |
CYP719A3 variant, (S)-scoulerine as substrate, microsomal protein used for determination |
673579 |
